Skip to main content
. Author manuscript; available in PMC: 2013 Sep 16.
Published in final edited form as: Am J Trop Med Hyg. 2009 Dec;81(6):950–960. doi: 10.4269/ajtmh.2009.09-0132

Table 4. Analysis of successive genotypes over infection-months for P. falciparum (left) and P. vivax (right).

New Allele? When Tx? P. faIciparum successive pfmsp-1B2 gerotyped FU points P. vivax succcssive Pv msp-3α gcnotypcd FU points
Part Anon ID# Genotype FU1 Genotype FU2 Genotype FU3 Genotype FU4 Part Anon ID# Genotype FUl Genotype FU2 Genotype FU3 Genotype FU4
Kl M20 R0 Kl M20 R0 Kl M20 R0 K1 M20 R0 Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2
NO, Tx at 1st FU 0001 195 195 195 0001 A_5_8 A_5_8
0002 195 195 0002 B_1_12 B_1_12
0003 195 195
0004 195 195
0005 170 170
0006 210 210
0007 200 200 200
NO, Tx later b/c ASYM at 1st FU 0008 195 195 0003 A,B_5_4 A_5_l
0009 195 195 0004 A_4_4 A_4_4
0010 195 195 0005 A_5_l A_5_l
0011 195 195 0006 A_6_4 A_6_4
0012 195 195 0007 A_6_4 A_6_4
0013 195 195 0008 A_6_7 A_6_4
0014 195 195 0009 A_6_4 A_6_4 A_6_4 A_6_4
0015 195 195 0010 A_3_13 A_3_6
0016 210 210 0011 C_1_14 C_1_4
0017 210 210
0018 210 210
0019 195 200 200
0020 195 200 195 200
0021 195 200 195 200
0022 170 200 170 200 200
0023 195 210 140 210 140
0024 195 200 195 195 200
NO, Tx later b/c PCR at 1st FU 0025 210 210 210 0012 A_5_8 A_5_8
0026 210 210 210 0013 A_6_4 A_6_4
0027 210 210 0014 B_1_12 B_1_12
0028 210 210 210 0015 B_1_12 B_1_12
0029 210 210 210 210 0016 A_6_4 A_6_4 A_6_14
0030 195 210 195 210
0031 195 195 195
0032 195 195 195
0033 195 140 195 140 195 140 195
0034 195 195 195
0035 195 195 195 195
0036 195 195 195
0037 195 195
0038 195 195
0039 195 195
0040 195 195
0041 195 195
0042 195 195
0043 195 195
0044 195 195
NO, selflimited 0045 210 210 210 0017 A_5_l A_6_4 A_6_4 A_6_4
0046 195 195 0018 A_6_4 A_6_4
0047 170 170 0019 A_10_13 A_5_l
0048 195 195 0020 A_5_1 A_6_4 A_5_1
0049 195 195 0021 A_5_1 A_5_l A_5_1
0050 195 195 195 195 0022 A_5_l A_5_1
0051 195 195 195 0023 A_6_4 A_6_4
0052 170 170
0053 210 210
00J4 210 210
0055 210 210
0056 210 210
YES, Tx at 1 st FU 0057 210 195 0024 A_4_4 A_8_4 A_4_4
YES, Tx later b/c ASYM at 1st FU 0025 A_6_4 A,B_2_12 A_4_4
0026 A_5_6 A_5_1 A_6_4 A_5_1 A_6_4
0027 A_6_4 A_5_l
0028 B_1_12 B_1_12 A_6_4
0029 A_5_8 A_4_4
0030 A_4_4 A_6_4 A_6_4 A_5_8
YES, Tx laterb/c PCR at 1st FU 0058 210 195 210 195 210 0031 A_3_l1 A_5_1
0032 A_5_8 A_4_4
0033 C_7_4 C_3_4
0034 A_3_6 A_5_l
0035 A_5_8 A_3_6
0036 A_5_8 B_6_12
0037 B_l_12 A_6_4
0038 A_4_4 A_4_4 A_3_6
0039 A_5_4 A_5_14 A_5_l A_6_4
0040 A_6_11 A_6_4 A_5_1 A_6_4

Tx = treatment; Part. anon ID no. = participant anonymous ID number; ASYM = asymptomatic (no reported or measured fever > 37.5°C, hematocrit > 30%, parasitemia < 5,000/mL); M20, Mad20; R0, RO33; FU = follow-up.